135 related articles for article (PubMed ID: 3321648)
1. Role of immunosuppressive drugs for prevention of graft-v-host disease after human HLA matched bone marrow transplantation.
Gluckman E; Devergie A; Lokiec F; Traineau R; Cosset JM; Lemercier N; Varrin F; Cavazzana M; de Castro H; Meletis J
Transplant Proc; 1987 Dec; 19(6 Suppl 7):61-5. PubMed ID: 3321648
[No Abstract] [Full Text] [Related]
2. Role of immunosuppressive drugs for prevention of graft-v-host disease after bone marrow transplantation.
Devergie A; Esperou H; Traineau R; Varrin F; Lehn P; Gluckman E
Nouv Rev Fr Hematol (1978); 1989; 31(2):73-5. PubMed ID: 2671932
[TBL] [Abstract][Full Text] [Related]
3. Regeneration of genetically restricted immune functions after human bone marrow transplantation: influence of four different strategies for graft-v-host disease prophylaxis.
Donnenberg AD; Hess AD; Duff SC; Bright EC; Noga SJ; Rowley SD; Saral R; Santos GW
Transplant Proc; 1987 Dec; 19(6 Suppl 7):144-52. PubMed ID: 3321641
[No Abstract] [Full Text] [Related]
4. Decreased incidence and severity of graft-versus-host disease in HLA matched and mismatched marrow recipients of cyclosporine and methotrexate.
Tollemar J; Ringdén O; Heimdahl A; Lönnqvist B; Sundberg B
Transplant Proc; 1988 Jun; 20(3 Suppl 3):470-9. PubMed ID: 3291283
[No Abstract] [Full Text] [Related]
5. Graft-versus-host disease after marrow transplantation.
Storb R
Prog Clin Biol Res; 1986; 224():139-57. PubMed ID: 3540990
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.
Schwinghammer TL; Bloom EJ
Clin Pharm; 1993 Oct; 12(10):736-61. PubMed ID: 8258255
[TBL] [Abstract][Full Text] [Related]
7. [Prevention of graft versus host disease by in vitro immunodepletion of the graft].
Maraninchi D
Nouv Rev Fr Hematol (1978); 1985; 27(6):349-50. PubMed ID: 3912729
[No Abstract] [Full Text] [Related]
8. T cell depletion of HLA and haploidentical marrow reduces graft-versus-host disease but it may impair a graft-versus-leukemia effect.
Henslee PJ; Thompson JS; Romond EH; Doukas MA; Metcalfe M; Marshall ME; MacDonald JS
Transplant Proc; 1987 Feb; 19(1 Pt 3):2701-6. PubMed ID: 3547948
[No Abstract] [Full Text] [Related]
9. An immunosuppressive myeloablative preparative regimen adequate for matched sibling transplant, inadequate in histoincompatible, T cell-depleted marrow cells in leukemia.
Kapoor N; Jung L; Bogardis C; DeBault L; Muneer R; Nitschke R; Good RA
Transplant Proc; 1984 Dec; 16(6):1419-24. PubMed ID: 6239418
[No Abstract] [Full Text] [Related]
10. A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
Sao H; Kitaori K; Kasai M; Shimokawa T; Kato C; Yamanishi H; Ueda R; Morishima Y
Int J Hematol; 1999 Jan; 69(1):27-35. PubMed ID: 10641440
[TBL] [Abstract][Full Text] [Related]
11. Effector cells of graft-versus-host disease, host resistance, and the graft-versus-leukemia effect: summary of a workshop on bone marrow transplantation.
Ringdén O; Deeg HJ; Beschorner W; Slavin S
Transplant Proc; 1987 Feb; 19(1 Pt 3):2758-61. PubMed ID: 3547953
[No Abstract] [Full Text] [Related]
12. Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation.
Atkinson K; Downs K
Bone Marrow Transplant; 1995 Dec; 16(6):755-8. PubMed ID: 8750265
[TBL] [Abstract][Full Text] [Related]
13. Use of cyclosporine for prevention of graft-versus-host disease after allogeneic bone marrow transplantation.
Gluckman E; Devergie A; Lokiec F
Transplant Proc; 1988 Jun; 20(3 Suppl 3):461-9. PubMed ID: 3291282
[No Abstract] [Full Text] [Related]
14. [Immunosuppression and the problems in homologous bone marrow transplantation].
Yabe H; Kato S
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):681-2. PubMed ID: 8963784
[No Abstract] [Full Text] [Related]
15. In vitro analysis of donor bone marrow following monoclonal antibody treatment for the prevention of acute graft versus host disease.
Kohler PC; Erickson C; Finlay JL; Trigg ME; Edwards B; Hong R; Hank JA; Billing R; Bozdech M; Sondel PM
Cancer Res; 1986 Oct; 46(10):5413-8. PubMed ID: 3530439
[TBL] [Abstract][Full Text] [Related]
16. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
[TBL] [Abstract][Full Text] [Related]
17. Combination prophylactic immunosuppression in bone marrow transplantation.
Szer J
Transplant Proc; 1989 Feb; 21(1 Pt 3):3011-2. PubMed ID: 2650415
[No Abstract] [Full Text] [Related]
18. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic evidence of partial chimerism after T cell-depleted allogeneic bone marrow transplantation in leukemic HLA-matched patients.
Berthéas MF; Mascret B; Maraninchi D; Lafage M; Blaise D; Fraisse J; Brizard CP; Carcassonne Y; Mawas C
Transplant Proc; 1987 Feb; 19(1 Pt 3):2738-40. PubMed ID: 3547951
[No Abstract] [Full Text] [Related]
20. Prospective randomized study of GVHD prevention using an anti IL2 receptor (CD25) MoAb after allogeneic bone marrow transplantation (BMT).
Blaise D; Guyotat D; Reiffers J; Olive D; Michallet M; Bellanger C; Vernant JP; Ifrah N; Attal M; Vilmer E
Bone Marrow Transplant; 1991; 7 Suppl 2():150. PubMed ID: 1878689
[No Abstract] [Full Text] [Related]
[Next] [New Search]
